NO178857C - Analogifremgangsmåte for fremstilling av terapeutisk aktive 3-indolylthioacetatderivater - Google Patents

Analogifremgangsmåte for fremstilling av terapeutisk aktive 3-indolylthioacetatderivater

Info

Publication number
NO178857C
NO178857C NO924126A NO924126A NO178857C NO 178857 C NO178857 C NO 178857C NO 924126 A NO924126 A NO 924126A NO 924126 A NO924126 A NO 924126A NO 178857 C NO178857 C NO 178857C
Authority
NO
Norway
Prior art keywords
derivatives
indolylthioacetate
preparation
therapeutically active
analogous process
Prior art date
Application number
NO924126A
Other languages
English (en)
Norwegian (no)
Other versions
NO924126D0 (no
NO178857B (no
NO924126L (no
Inventor
Francesco G Salituro
Bruce M Baron
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO924126D0 publication Critical patent/NO924126D0/no
Publication of NO924126L publication Critical patent/NO924126L/no
Publication of NO178857B publication Critical patent/NO178857B/no
Publication of NO178857C publication Critical patent/NO178857C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Lubricants (AREA)
  • Hard Magnetic Materials (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Catalysts (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO924126A 1990-04-25 1992-10-23 Analogifremgangsmåte for fremstilling av terapeutisk aktive 3-indolylthioacetatderivater NO178857C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/514,074 US5051442A (en) 1990-04-25 1990-04-25 3-indolyl thioacetate derivatives and NMDA receptor antagonistic use thereof
PCT/US1991/002179 WO1991016307A1 (fr) 1990-04-25 1991-03-28 Derives de 3-indolyle thioacetate

Publications (4)

Publication Number Publication Date
NO924126D0 NO924126D0 (no) 1992-10-23
NO924126L NO924126L (no) 1992-10-23
NO178857B NO178857B (no) 1996-03-11
NO178857C true NO178857C (no) 1996-06-19

Family

ID=24045696

Family Applications (1)

Application Number Title Priority Date Filing Date
NO924126A NO178857C (no) 1990-04-25 1992-10-23 Analogifremgangsmåte for fremstilling av terapeutisk aktive 3-indolylthioacetatderivater

Country Status (14)

Country Link
US (1) US5051442A (fr)
EP (1) EP0526478B1 (fr)
JP (1) JP3006881B2 (fr)
KR (1) KR0178281B1 (fr)
AT (1) ATE119882T1 (fr)
AU (1) AU646251B2 (fr)
CA (1) CA2081330C (fr)
DE (1) DE69108234T2 (fr)
DK (1) DK0526478T3 (fr)
ES (1) ES2072607T3 (fr)
FI (1) FI98454C (fr)
HU (1) HU213205B (fr)
NO (1) NO178857C (fr)
WO (1) WO1991016307A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5189054A (en) * 1990-11-02 1993-02-23 Merrell Dow Pharmaceuticals Inc. 3-amidoindolyl derivatives and pharmaceutical compositions thereof
US5318985A (en) * 1991-12-20 1994-06-07 Merrell Dow Pharmaceuticals Inc. Potentiation of NMDA antagonists
USRE39300E1 (en) 1993-01-28 2006-09-19 Virginia Commonwealth University Medical College Of Virginia Inhibiting the development of tolerance to and/or dependence on an addictive substance
US5321012A (en) * 1993-01-28 1994-06-14 Virginia Commonwealth University Medical College Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance
GB9311948D0 (en) * 1993-06-10 1993-07-28 Zeneca Ltd Substituted nitrogen heterocycles
US5424329A (en) * 1993-08-18 1995-06-13 Warner-Lambert Company Indole-2-carboxamides as inhibitors of cell adhesion
US5801168A (en) * 1994-06-09 1998-09-01 Zeneca Limited Substituted nitrogen heterocycles
PT802183E (pt) * 1996-04-19 2002-03-28 American Home Prod Agentes estrogenicos
US6069153A (en) * 1998-05-12 2000-05-30 American Home Products Corporation Indenoindoles and benzocarbazoles as estrogenic agents
US6479535B1 (en) 1998-05-15 2002-11-12 Wyeth 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations
US6159959A (en) * 1999-05-06 2000-12-12 American Home Products Corporation Combined estrogen and antiestrogen therapy
AR081930A1 (es) 2010-06-16 2012-10-31 Ardea Biosciences Inc Compuestos de tioacetato
BR112012032193A2 (pt) 2010-06-16 2019-09-24 Ardea Biosciences Inc composto, composiçoes e métodos de uso de feniltioacetato
EP3501520A1 (fr) 2011-11-03 2019-06-26 Ardea Biosciences, Inc. Composé de pyridine 3,4-disubstituée, procédés d'utilisation et compositions le comprenant

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675332A (en) * 1984-12-10 1987-06-23 Warner-Lambert Company Acidic tetrazolyl substituted indole compounds and their use as antiallergy agents
NZ222878A (en) * 1986-12-17 1991-02-26 Merck Frosst Canada Inc 3-hetero-substituted-n-benzyl-indole derivatives, and pharmaceutical compositions
US4960786A (en) * 1989-04-24 1990-10-02 Merrell Dow Pharmaceuticals Inc. Excitatory amino acid antagonists
JPH0347123A (ja) * 1989-05-05 1991-02-28 G D Searle & Co インドール―２―カルボキシレート化合物類を含有するｃｎｓ疾患治療用組成物

Also Published As

Publication number Publication date
FI98454C (fi) 1997-06-25
DE69108234T2 (de) 1995-08-24
HU9203336D0 (en) 1993-01-28
JPH07500567A (ja) 1995-01-19
NO924126D0 (no) 1992-10-23
ATE119882T1 (de) 1995-04-15
ES2072607T3 (es) 1995-07-16
FI98454B (fi) 1997-03-14
HUT64744A (en) 1994-02-28
FI924642L (fi) 1992-10-14
WO1991016307A1 (fr) 1991-10-31
NO178857B (no) 1996-03-11
AU7650091A (en) 1991-11-11
CA2081330C (fr) 2002-02-05
CA2081330A1 (fr) 1991-10-26
EP0526478B1 (fr) 1995-03-15
DE69108234D1 (en) 1995-04-20
AU646251B2 (en) 1994-02-17
JP3006881B2 (ja) 2000-02-07
FI924642A0 (fi) 1992-10-14
HU213205B (en) 1997-03-28
EP0526478A1 (fr) 1993-02-10
US5051442A (en) 1991-09-24
KR937000438A (ko) 1993-03-15
NO924126L (no) 1992-10-23
DK0526478T3 (da) 1995-05-29
KR0178281B1 (ko) 1999-03-20

Similar Documents

Publication Publication Date Title
FI98455B (fi) Menetelmä terapeuttisesti aktiivisten indolijohdannaisten valmistamiseksi
FI914905L (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten merkaptoasetyyliamidopyrrolo- ja -pyridobentsatsepiinijohdannaisten valmistamiseksi
NO178857C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 3-indolylthioacetatderivater
FI925737A7 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten indol-3-yylialkyylipiperatsiinijohdannaisten valmistamiseksi
FI923527L (fi) Menetelmä terapeuttisesti käyttökelpoisten 3-piperidino-4-hydroksikromaanijohdannaisten valmistamiseksi
NO903941D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive diazepinon-derivater.
NO177141C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive aminosyreantagonister
PT86827A (pt) Process for preparing substituted alkylamides of teicoplanin cocompounds
DE69230224D1 (de) Potenzierung von nmda-antagonisten
FI103202B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten 4-sulfonamido-1,4-dihydrokinoliiinijohdannaisten valmistamiseksi
FI98456B (fi) Menetelmä terapeuttisesti aktiivisten 1-piperidinyylialkanoyyliaryylisulfonamidijohdannaisten valmistamiseksi
NO952713L (no) Fremgangsmåte for fremstilling av substituerte indolonderivater
FI97388B (fi) Menetelmä heterosyklisten NMDA-antagonistien valmistamiseksi
NO177710C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive slektede analoger
NO178375C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive NMDA-antagonister
NO178782C (no) Fremgangsmåte for fremstilling av et farmasöytisk akseptabelt gelpreparat
FI910448A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten 1,2,3,3a,8,8a-heksahydro-1,3a,8-trimetyylipyrrolo/2,3b/indolijohdannaisten valmistamiseksi
NO179909C (no) Analogifremgangsmåte for fremstilling av terapeutisk avtive 6-substituerte purinylpiperazinderivater
FI912733L (fi) Menetelmä terapeuttisesti käyttökelpoisten /(1-aryylipyrrolidin-2-yyli)metyyli/piperatsiinijohdannaisten valmistamiseksi

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN SEPTEMBER 2003